Cambium Bio Ltd (CMBDA) Cash Flow Statement

0.400
0.0000.00%

20min DelayMarket Closed Jul 12 11:37 AET

2.45MMarket Cap-0.73P/E (Static)

Cambium Bio Ltd (CMBDA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Operating cash flow (direct method)

Cash income from operating activities

41.48%1.2M

-88.16%849.41K

125.54%7.17M

3.18M

Revenue from customers

657.29%151.46K

-99.70%20K

303.05%6.61M

--1.64M

Income from government grants

----

--829.41K

----

Other cash income from operating activities

--1.05M

----

-63.23%566.75K

--1.54M

Cash paid

59.90%-1.76M

2.75%-4.4M

4.96%-4.52M

-4.76M

Payments to suppliers for goods and services

59.90%-1.76M

2.75%-4.4M

4.96%-4.52M

---4.76M

Direct interest paid

-137.31%-98.27K

82.13%-41.41K

31.68%-231.67K

---339.1K

Direct interest received

3,700.00%38

-91.67%1

-98.46%12

--780

Operating cash flow

81.61%-660.46K

-248.48%-3.59M

226.13%2.42M

---1.92M

Investing cash flow

Cash flow from continuing investing activities

-468.53%-48.13K

-8.76%-8.47K

-148.10%-7.78K

16.18K

Net PPE purchase and sale

430.44%27.98K

-8.76%-8.47K

-243.35%-7.78K

--5.43K

Net business purchase and sale

----

--10.75K

Net other investing changes

---76.11K

----

Cash from discontinued investing activities

Investing cash flow

-468.53%-48.13K

-8.76%-8.47K

-148.10%-7.78K

--16.18K

Financing cash flow

Cash flow from continuing financing activities

1,036.54%916.27K

-124.46%-97.84K

-84.78%400K

2.63M

Net issuance payments of debt

460.49%947.02K

76.12%-262.7K

14.06%-1.1M

---1.28M

Net common stock issuance

----

-61.36%1.5M

--3.88M

Net other financing activities

-118.65%-30.75K

--164.87K

----

--25.93K

Cash from discontinued financing activities

Financing cash flow

1,036.54%916.27K

-124.46%-97.84K

-84.78%400K

--2.63M

Net cash flow

Beginning cash position

-97.49%95.12K

286.28%3.79M

284.34%981.85K

--255.46K

Current changes in cash

105.62%207.67K

-231.55%-3.7M

286.97%2.81M

--726.38K

End cash Position

218.32%302.79K

-97.49%95.12K

286.28%3.79M

--981.85K

Free cash from

81.65%-660.46K

-249.31%-3.6M

225.72%2.41M

---1.92M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities	41.48%1.2M	-88.16%849.41K	125.54%7.17M	3.18M
Revenue from customers	657.29%151.46K	-99.70%20K	303.05%6.61M	--1.64M
Income from government grants	----	--829.41K	----	----
Other cash income from operating activities	--1.05M	----	-63.23%566.75K	--1.54M
Cash paid	59.90%-1.76M	2.75%-4.4M	4.96%-4.52M	-4.76M
Payments to suppliers for goods and services	59.90%-1.76M	2.75%-4.4M	4.96%-4.52M	---4.76M
Direct interest paid	-137.31%-98.27K	82.13%-41.41K	31.68%-231.67K	---339.1K
Direct interest received	3,700.00%38	-91.67%1	-98.46%12	--780
Operating cash flow	81.61%-660.46K	-248.48%-3.59M	226.13%2.42M	---1.92M
Investing cash flow
Cash flow from continuing investing activities	-468.53%-48.13K	-8.76%-8.47K	-148.10%-7.78K	16.18K
Net PPE purchase and sale	430.44%27.98K	-8.76%-8.47K	-243.35%-7.78K	--5.43K
Net business purchase and sale	----	----	----	--10.75K
Net other investing changes	---76.11K	----	----	----
Cash from discontinued investing activities
Investing cash flow	-468.53%-48.13K	-8.76%-8.47K	-148.10%-7.78K	--16.18K
Financing cash flow
Cash flow from continuing financing activities	1,036.54%916.27K	-124.46%-97.84K	-84.78%400K	2.63M
Net issuance payments of debt	460.49%947.02K	76.12%-262.7K	14.06%-1.1M	---1.28M
Net common stock issuance	----	----	-61.36%1.5M	--3.88M
Net other financing activities	-118.65%-30.75K	--164.87K	----	--25.93K
Cash from discontinued financing activities
Financing cash flow	1,036.54%916.27K	-124.46%-97.84K	-84.78%400K	--2.63M
Net cash flow
Beginning cash position	-97.49%95.12K	286.28%3.79M	284.34%981.85K	--255.46K
Current changes in cash	105.62%207.67K	-231.55%-3.7M	286.97%2.81M	--726.38K
End cash Position	218.32%302.79K	-97.49%95.12K	286.28%3.79M	--981.85K
Free cash from	81.65%-660.46K	-249.31%-3.6M	225.72%2.41M	---1.92M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"